{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:10:38Z","timestamp":1790021438733,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012719","name":"Scottish Microbiology Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012719","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 581"],"award-info":[{"award-number":["SFB 581"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000894","name":"Spinal Muscular Atrophy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000894","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.nbd.2009.08.014","type":"journal-article","created":{"date-parts":[[2009,9,5]],"date-time":"2009-09-05T05:11:43Z","timestamp":1252127503000},"page":"477-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Valproic acid blocks excitability in SMA type I mouse motor neurons"],"prefix":"10.1016","volume":"36","author":[{"given":"Kristen","family":"Rak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara Dorothea","family":"Lechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Drexl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sendtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Jablonka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2009.08.014_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0304-3940(85)90381-7","article-title":"Depression of hippocampal low calcium field bursts by the antiepileptic drug valproic acid","volume":"60","author":"Agopyan","year":"1985","journal-title":"Neurosci. Lett."},{"issue":"Suppl. 3","key":"10.1016\/j.nbd.2009.08.014_bib2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1528-1157.43.s.3.5.x","article-title":"Children versus adults: pharmacokinetic and adverse-effect differences","volume":"43","author":"Anderson","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2009.08.014_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1749-6632.2003.tb07517.x","article-title":"Antiepileptic drugs and apoptosis in the developing brain","volume":"993","author":"Bittigau","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.nbd.2009.08.014_bib4","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1093\/hmg\/ddg256","article-title":"Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy","volume":"12","author":"Brichta","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2009.08.014_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/nbdi.1996.0010","article-title":"The neurobiology of childhood spinal muscular atrophy","volume":"3","author":"Crawford","year":"1993","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2009.08.014_bib6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1046\/j.1471-4159.1999.0720500.x","article-title":"Excitotoxic death of a subset of embryonic rat motor neurons in vitro","volume":"72","author":"Fryer","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.08.014_bib7","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/nn1524","article-title":"Bag1 is essential for differentiation and survival of hematopoietic and neuronal cells","volume":"8","author":"G\u00f6tz","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2009.08.014_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1471-4159.2006.03868.x","article-title":"In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy","volume":"98","author":"Hahnen","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2009.08.014_bib9","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/hmg\/ddn357","article-title":"Survival motoneuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and be bypassed by histone deacetylase inhibition","volume":"18","author":"Hauke","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2009.08.014_bib10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1083\/jcb.200703187","article-title":"Defective Ca2+ channel clustering in axon terminals disturbs excitability in motoneurons in spinal muscular atrophy","volume":"179","author":"Jablonka","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2009.08.014_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0304-3940(90)90416-7","article-title":"Valproic acid selectively reduces the low-threshold (T) calcium current in rat nodose neurons","volume":"116","author":"Kelly","year":"1990","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2009.08.014_bib12","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/hmg\/ddi130","article-title":"The role of histone acetylation in SMN gene expression","volume":"14","author":"Kernochan","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2009.08.014_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2009.08.014_bib14","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","article-title":"A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy","volume":"96","author":"Lorson","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2009.08.014_bib15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy","volume":"16","author":"Loscher","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.nbd.2009.08.014_bib16","doi-asserted-by":"crossref","first-page":"14803","DOI":"10.1074\/jbc.M308225200","article-title":"Identification of a novel cyclic AMP-response element (CRE-II) and the role of CREB-1 in the cAMP-induced expression of the survival motor neuron (SMN) gene","volume":"279","author":"Majumder","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2009.08.014_bib17","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1083\/jcb.200303168","article-title":"Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding","volume":"162","author":"McWhorter","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2009.08.014_bib18","first-page":"177","article-title":"Clinical and surface EMG characterisics of valproate induced tremors","volume":"45","author":"Mehndiratta","year":"2005","journal-title":"Electromyogr. Clin. Neurophysiol."},{"key":"10.1016\/j.nbd.2009.08.014_bib19","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","article-title":"A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2","volume":"8","author":"Monani","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2009.08.014_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/hmg\/9.3.333","article-title":"The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(\u2212\/\u2212) mice and results in a mouse with spinal muscular atrophy [In Process Citation]","volume":"9","author":"Monani","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2009.08.014_bib21","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0092-8674(00)82001-2","article-title":"The transcriptional coactivators p300 and CBP are histone acetyltransferases","volume":"87","author":"Ogryzko","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2009.08.014_bib22","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.pnpbp.2004.05.041","article-title":"Encephalopathy and myoclonus triggered by valproic acid","volume":"28","author":"Reif","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2009.08.014_bib23","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1083\/jcb.200304128","article-title":"Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons","volume":"163","author":"Rossoll","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2009.08.014_bib24","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ana.10743","article-title":"Valproic acid increases SMN levels in spinal muscular atrophy patient cells","volume":"54","author":"Sumner","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2009.08.014_bib25","first-page":"4","article-title":"Phase II open label study of valproic acid in spinal muscular atrophy","volume":"e5268","author":"Swoboda","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2009.08.014_bib26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.brainres.2006.10.086","article-title":"The ataxic groggy rat has a missense mutation in the P\/Q-type voltage-gated Ca2+ channel alpha1A subunit gene and exhibits absence seizures","volume":"1133","author":"Tokuda","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2009.08.014_bib27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1747-0285.2006.00369.x","article-title":"Valproic acid promotes neurite outgrowth in PC12 cells independent from regulation of the survival of motoneuron protein","volume":"67","author":"Van Bergeijk","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.nbd.2009.08.014_bib28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00228395","article-title":"Valproate and sodium currents in cultured hippocampal neurons","volume":"93","author":"Van den Berg","year":"1993","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.nbd.2009.08.014_bib29","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/01.wnl.0000231139.26253.d0","article-title":"Valproate may improve strength and function in patients with type III\/IV spinal muscle atrophy","volume":"67","author":"Weihl","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2009.08.014_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/83960","article-title":"Specific function of B-Raf in mediating survival of embryonic motoneurons and sensory neurons","volume":"4","author":"Wiese","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2009.08.014_bib31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0920-1211(91)90028-E","article-title":"Comparison of valproate concentrations in human plasma, CSF and brain tissue after administration of different formulations of valproate or valpromide","volume":"9","author":"Wieser","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nbd.2009.08.014_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-3-540-34449-0_6","article-title":"Spinal muscular atrophy and therapeutic prospects","volume":"44","author":"Wirth","year":"2006","journal-title":"Prog. Mol. Subcell. Biol."},{"key":"10.1016\/j.nbd.2009.08.014_bib33","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00439-006-0156-7","article-title":"Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number","volume":"119","author":"Wirth","year":"2006","journal-title":"Hum. Genet."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996109002411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996109002411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:04:15Z","timestamp":1760850255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996109002411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0969996109002411"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2009.08.014","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproic acid blocks excitability in SMA type I mouse motor neurons","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2009.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}